Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting.

Saved in:
Bibliographic Details
Title: Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting.
Authors: Belcaid, L.1 (AUTHOR) laila.belcaid.01@regionh.dk, Højgaard, M.1 (AUTHOR), Tuxen, I.1 (AUTHOR), Spanggaard, I.1 (AUTHOR), Lassen, U.1 (AUTHOR), Robinson, L.2 (AUTHOR), Rossing, M.2 (AUTHOR), Bagger, F.2 (AUTHOR), Ahlborn, L.B.2 (AUTHOR), Schmidt, A.Y.2 (AUTHOR), Hasselby, J.P.3 (AUTHOR), Santoni-Rugiu, E.3 (AUTHOR), Nielsen, F.C.2 (AUTHOR), Yde, C.W.2 (AUTHOR), Rohrberg, K.1 (AUTHOR)
Source: Annals of Oncology. Sep2025, Vol. 36 Issue 9, p1078-1087. 10p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.04.004